New pain pill SBS-147 enters first human safety trial
Symptom relief
Recruiting now
This early-stage study tests the safety of an experimental pain drug called SBS-147 in 80 healthy adults. Some participants get the drug, others a placebo. The study has two parts: a single dose group and a group that takes the drug daily for a week. Researchers will monitor side…
Phase: PHASE1 • Sponsor: Sparian Biosciences, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC